Pacific Biosciences Of California PACB
NASDAQ PACB
$2.20 +0.37 (+20.27%)
As of: Sep 30, 2026 · 10:25 AM EDT

Pacific Biosciences Of California (PACB) EBIT Margin (2010 - 2026)

Updated

Pacific Biosciences Of California's EBIT Margin was -114.36% in Q2 2026, down 1.57 percentage points from -112.79% a year earlier and down 91.89 percentage points from the prior quarter.

Analysis

Pacific Biosciences Of California (PACB) EBIT Margin (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Pacific Biosciences Of California's EBIT Margin was -83.53% through Jun 30, 2026, up 359.04 percentage points year-over-year; for FY2025, it was -346.15%, down 38.18 percentage points from FY2024.

  • EBIT Margin shows a five-year change of -213.84 percentage points (FY2020 to FY2025).
  • In earlier years, EBIT Margin was -307.97% in FY2024 (-141.17 pp), -166.80% in FY2023 (+72.63 pp), -239.43% in FY2022 (-78.19 pp) and -161.24% in FY2021 (-28.92 pp).
  • The Q2 2026 figure marks the lowest quarterly EBIT Margin since Q1 2025.
  • Compared with a year earlier, EBIT Margin was higher in four of the last eight quarters, with an average year-over-year change of +83.23 percentage points.
  • The best year-over-year quarter for EBIT Margin over five years was Q1 2026 (a gain of 1132.03 percentage points); the worst was Q1 2025 (a drop of 944.87 percentage points).
  • Per Business Quant data, PACB's EBIT Margin in the three quarters before Q2 2026 was -22.48% (Q1 2026), -92.28% (Q4 2025) and -101.13% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 13.44%
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 33.60%
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 18.08%
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 25.18%
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 21.65%
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 13.31%
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 29.48%
10 Pacific Biosciences Of California 531.49 Mn -559.51 Mn 12.64 Mn -114.36%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -114.36%
Mar 31, 2026 -22.48%
Dec 31, 2025 -92.28%
Sep 30, 2025 -101.13%
Jun 30, 2025 -112.79%
Mar 31, 2025 -1,154.51%
Dec 31, 2024 -390.14%
Sep 30, 2024 -160.32%
Jun 30, 2024 -488.28%
Mar 31, 2024 -209.64%
Dec 31, 2023 -150.02%
Sep 30, 2023 -148.12%
Jun 30, 2023 -153.82%
Mar 31, 2023 -234.58%
Dec 31, 2022 -318.37%
Sep 30, 2022 -230.94%
Jun 30, 2022 -191.64%
Mar 31, 2022 -233.69%
Dec 31, 2021 -179.56%
Sep 30, 2021 -213.48%
API Access

Pacific Biosciences Of California EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=PACB&period=max&api_key=YOUR_API_KEY